Pierre Bulpa

Pierre Bulpa is an active researcher with expertise in hematology, pulmonary medicine, and critical care, focusing on thrombotic complications in severe COVID-19 and lung transplantation. His work intersects with the UN Sustainable Development Goals related to health and well-being (SDG 3) and innovation (SDG 9). Collaborations span international institutions, particularly in hemostasis and respiratory disease research.

• Key research areas: Thrombosis in critically ill patients, lung transplantation, methadone's role in transplant outcomes, and diagnostic algorithms for pulmonary aspergillosis.
• Recent publications (2020–2023) emphasize longitudinal hemostasis disturbances in COVID-19, validated biomarkers, and data-driven clinical insights.
• Collaborations include multidisciplinary teams across Belgium and France, with contributions to clinical guidelines.